Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Friedman

Showing results (1301-1310 of 1,475) with videos related to

Pageof 148
Sort By:
Cancer|August 24, 2005
Survival analysis of presumptive prognostic markers among oligodendrogliomasRoger E McLendon, James E Herndon, Bryan West, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 13, 2010
Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's diseaseJoseph H Friedman, Guido Alves, Peter Hagell, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 5, 2008
Scales to assess psychosis in Parkinson's disease: Critique and recommendationsHubert H Fernandez, Dag Aarsland, Gilles Fénelon, et al.
Cancer Immunology Research|November 13, 2014
Severe adverse immunologic reaction in a patient with glioblastoma receiving autologous dendritic cell vaccines combined with GM-CSF and dose-intensified temozolomideDuane A Mitchell, Elias J Sayour, Elizabeth Reap, et al.
The Journal of Clinical Psychiatry|January 25, 2024
The Clinician's Tardive Inventory (CTI): A New Clinical Tool for Documenting and Rating Tardive DyskinesiaRichard M Trosch, Cynthia L Comella, Stanley N Caroff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
Regional treatment of epidermal growth factor receptor vIII-expressing neoplastic meningitis with a single-chain immunotoxin, MR-1G E Archer, J H Sampson, I A Lorimer, et al.
The Journal of Investigative Dermatology|June 1, 1992
Environmental risk factors in endemic pemphigus foliaceus (Fogo selvagem). "The Cooperative Group on Fogo Selvagem Research"C Lombardi, P C Borges, A Chaul, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 19, 2019
Building more accurate decision trees with the additive treeJosé Marcio Luna, Efstathios D Gennatas, Lyle H Ungar, et al.
Journal of Neuro-Oncology|February 13, 2009
Assessment of physical functioning in recurrent glioma: preliminary comparison of performance status to functional capacity testingLee W Jones, Rachel-Rose Cohen, Stephanie K Mabe, et al.
Expert Review of Anticancer Therapy|May 13, 2008
Immunotherapy against angiogenesis-associated targets: evidence and implications for the treatment of malignant gliomaRichard G Everson, Michael W Graner, Matthias Gromeier, et al.
Pageof 148

Showing results (1301-1310 of 1,475) with videos related to

Sort By:
Pageof 148
Cancer|August 24, 2005
Survival analysis of presumptive prognostic markers among oligodendrogliomasRoger E McLendon, James E Herndon, Bryan West, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 13, 2010
Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's diseaseJoseph H Friedman, Guido Alves, Peter Hagell, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 5, 2008
Scales to assess psychosis in Parkinson's disease: Critique and recommendationsHubert H Fernandez, Dag Aarsland, Gilles Fénelon, et al.
Cancer Immunology Research|November 13, 2014
Severe adverse immunologic reaction in a patient with glioblastoma receiving autologous dendritic cell vaccines combined with GM-CSF and dose-intensified temozolomideDuane A Mitchell, Elias J Sayour, Elizabeth Reap, et al.
The Journal of Clinical Psychiatry|January 25, 2024
The Clinician's Tardive Inventory (CTI): A New Clinical Tool for Documenting and Rating Tardive DyskinesiaRichard M Trosch, Cynthia L Comella, Stanley N Caroff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
Regional treatment of epidermal growth factor receptor vIII-expressing neoplastic meningitis with a single-chain immunotoxin, MR-1G E Archer, J H Sampson, I A Lorimer, et al.
The Journal of Investigative Dermatology|June 1, 1992
Environmental risk factors in endemic pemphigus foliaceus (Fogo selvagem). "The Cooperative Group on Fogo Selvagem Research"C Lombardi, P C Borges, A Chaul, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 19, 2019
Building more accurate decision trees with the additive treeJosé Marcio Luna, Efstathios D Gennatas, Lyle H Ungar, et al.
Journal of Neuro-Oncology|February 13, 2009
Assessment of physical functioning in recurrent glioma: preliminary comparison of performance status to functional capacity testingLee W Jones, Rachel-Rose Cohen, Stephanie K Mabe, et al.
Expert Review of Anticancer Therapy|May 13, 2008
Immunotherapy against angiogenesis-associated targets: evidence and implications for the treatment of malignant gliomaRichard G Everson, Michael W Graner, Matthias Gromeier, et al.
Pageof 148